Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV react...

Descripción completa

Detalles Bibliográficos
Autores principales: Colaci, Michele, Sebastiani, Marco, Sandri, Gilda, Meacci, Marisa, Ferri, Clodoveo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336221/
https://www.ncbi.nlm.nih.gov/pubmed/22570799
http://dx.doi.org/10.1155/2011/530568
Descripción
Sumario:TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.

Ejemplares similares